<DOC>
	<DOCNO>NCT02991742</DOCNO>
	<brief_summary>Contrast media-induced nephropathy follow diagnostic therapeutic cardiac catheterization .</brief_summary>
	<brief_title>Ioxaglate Versus Iodixanol Prevention Contrast-induced Nephropathy High-risk Patients ( IDPC Trial )</brief_title>
	<detailed_description>Contrast-induced acute kidney injury represent serious complication procedure require administration iodinate contrast medium associate need dialysis , prolonged hospitalization , increased cost , mortality . Contrast-induced nephropathy define increase 25 % serum creatinine procedure . Iodixanol , nonionic , dimeric , iso-osmolar contrast medium may less nephrotoxic low-osmolar contrast medium high-risk patient . The purpose study compare iodixanol versus ioxaglate high risk patient 48 96 hour procedure use contrast .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<criteria>At least one follow criterion Aged 70 yearsold Chronic renal failure Diabetes mellitus Congestive heart failure leave ventricular ejection fraction &lt; 0.50 Shock intraaortic ballon pump use Urgency emergency procedure Patients dialysis Allergy iodine Patient refusal inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>nephropathy</keyword>
	<keyword>catheterization</keyword>
	<keyword>contrast medium</keyword>
	<keyword>ioxaglate</keyword>
	<keyword>iodixanol</keyword>
	<keyword>high risk</keyword>
	<keyword>prevention</keyword>
</DOC>